Energy & Resources push the market higher (RIO, CYB)
WHAT MATTERED TODAY
Stocks recovered most of the losses incurred the prior session today – Energy and Resources the main game in town however the buying was very broad based with all sectors ticking higher. US Futures provided a positive backdrop – up around +0.2% for most of our session while Asian markets were also positive.
Data out of China today was mixed to mostly weaker – industrial production & retail sales both on the softer side of expectations, however the bad news is good thematic seems obvious here, with more chance for central bank stimulus as Trump applies higher tariffs to Chinese goods.
Chinese data today
Overall today, the ASX 200 added +44 points or +0.71% to 6284. Dow Futures are trading up +60pts / +0.23%.
ASX 200 Chart
ASX 200 Chart
CATCHING OUR EYE;
Iron Ore Miners we focussed on Fortescue (FMG) in the income note today after they stormed higher yesterday, however it was others in the sector that performed better on today’s session. Rio Tinto, a stock we added to the income portfolio yesterday led the charge adding more than 2% to close at $98.31 – RIO looks strong for another test of recent highs. A bullish note on Iron Ore out today from First NZ Capital Securities saying prices will peak at $110 next quarter, when the port stockpiles will be completely depleted of available supplies. Stockpiles will then slowly rebound, with prices easing from the fourth quarter, it said. Click here to view todays note on Fortescue Metals (FMG)
Rio Tinto (RIO) Chart
CYBG (CYB) +0.58% reported at 4pm today so the reaction will happen first in the UK tonight, however it looks like the 1H result is in line to a slight beat. They printed pre-tax profit of GBP286m which was above the GBP272m expected plus they reaffirmed their 2019 outlook, however it was a low quality beat at best.
CYBG (CYB) Chart
Broker moves:
· Woolworths Group Downgraded to Neutral at UBS; PT A$32.90
· Infratil Downgraded to Neutral at Forsyth Barr; PT NZ$4.40
· Wesfarmers Cut to Neutral at Macquarie; Price Target A$37.13
· Mayne Pharma Downgraded to Hold at Bell Potter; PT A$0.62
· Mayne Pharma Downgraded to Neutral at Credit Suisse; PT A$0.64
· Altium Upgraded to Buy at Bell Potter; Price Target A$37.50
· Scentre Group Upgraded to Outperform at Credit Suisse; PT A$4.20
· OZ Minerals Reinstated at Goldman With Neutral; PT A$9.70
· AusNet Downgraded to Sell at Citi
OUR CALLS
No changes today
Have a great night
James & the Market Matters Team
Disclosure
Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.
Disclaimer
All figures contained from sources believed to be accurate. Market Matters does not make any representation of warranty as to the accuracy of the figures and disclaims any liability resulting from any inaccuracy. Prices as at 15/05/2019
Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The MarketMatters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.
The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor. Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.
The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports. Market Matters may publish content sourced from external content providers.
If you rely on a Report, you do so at your own risk. Past performance is not an indication of future performance. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.
